attention to its clinical inadequacy. The laboratory strategy must also permit the rapid exclusion of AMI-the slope value cannot be used for that purpose (PV of a negative result=0.87).
Our strategy! based on two CK measurements, with CKMB as a second line test in a minority of patients, allows the rapid confirmation or exclusion of AM1 (sensitivity = 100V0, PV of a negative result = 1 *O).
We disagree that a single high CK on admission may be used to make the diagnosis because there are too many other causes of raised CK.
The ECG permits the rapid diagnosis of AM1 and this is usually used to make the decision to give thrombolytic therapy. However, the increasing use of thrombolytic therapy-and the need to administer it to the right patients-provides us all with a challenge. 
Author's reply
The old lady that lives down the street from Dr Chandler will probably, sometime during her golden years, fall and fracture her hip. If she uses long-acting barbiturates, because she does not sleep well since the recent death of her husband, she has an increased risk of falling compared to her previous state. That increased risk is described in terms of the odds ratio and is 5:2.' So she is five-times more likely now to fall and fracture her hip, than before her husband's death. However, all such measurements are subject to error, the 95% error range of the odds ratio is now actually from 0.6 to 45. We merely mention this study because it illustrates the fact that today we have to learn newer and better ways of assessing relationships between variables, and odds ratios and confidence limits are markedly superior to earlier usages. We claim no originality in our use of these techniques, we did give the sources for our approach in an earlier publication,' but we do believe that clinical chemists must learn to use them if they are to deliver an economic and appropriate service to their patients. All of the terms used are MeSH (medical subject headings) terms and can be searched in MEDLINE to obtain relevant articles for further enlightenment. The fact that they are MeSH terms at all indicates their growing significance in the medical literature. Alkaline phosphatase and rickets in the premature infant I read with interest the excellent review by Mayne and Kovar,' but would like to draw attention to two misquotations of our paper on alkaline phosphatase isoenzymes in infants.' First, all the preterm infants in our study received formula milk feeds (although two babies also received some breast milk in addition to formula); we were therefore unable to comment on the behaviour of fetal intestinal isoenzyme in exclusively breast-fed infants. Secondly, we found that in very preterm infants, the fetal intestinal isoenzyme may comprise up to 50% of total alkaline phosphatase activity by the third postnatal week, not 10% as stated by the authors. This obviously has important implications for the interpretation of increased alkaline phosphatase activities in the first month of postnatal life, and may limit the ability of total alkaline phosphatase activity to provide a reliable early prediction of rickets in the very preterm infants who are most at risk. However, I would agree with Mayne and Kovar that, by the end of the sixth postnatal week, when clinical rickets may begin to appear, the fetal intestinal isoenzyme
